News tagged with novartis
Continuous drug manufacturing offers speed, lower costs
Traditional drug manufacturing is a time-consuming process. Active pharmaceutical ingredients are synthesized in a chemical manufacturing plant and then shipped to another site, where they are converted into ...
Mar 12, 2012 |
5 / 5 (4) |
0
Novel epigenetic patterns involved in cell fate regulation
(PhysOrg.com) -- Scientists from the Friedrich Miescher Institute for Biomedical Research (FMI) publish exciting new results on the regulation of cell fate in the scientific journal Nature. They identified ...
Dec 15, 2011 |
5 / 5 (1) |
0
|
Scientists identify new class of antimalarial compounds
An international team led by scientists from the Genomics Institute of the Novartis Research Foundation (GNF) and The Scripps Research Institute has discovered a family of chemical compounds that could lead ...
Nov 17, 2011 |
3 / 5 (2) |
2
|
UNICEF discloses vaccine prices for 1st time
UNICEF is for the first time publicizing what drugmakers charge it for vaccines, as the world's biggest buyer of lifesaving immunizations aims to spark price competition in the face of rising costs.
Medicine & Health / Medications
May 29, 2011 |
5 / 5 (3) |
1
Is a repeat flu shot needed? This fall, maybe not
(AP) -- Vaccine makers said this month they plan to make a record amount of flu vaccine for this fall and winter - enough for more than half the population. It's just not clear all those people will need ...
Medicine & Health / Diseases, Conditions, Syndromes
May 27, 2011 |
not rated yet |
0
New insights for a therapeutic approach in glioblastoma
(PhysOrg.com) -- Scientists from the Friedrich Miescher Institute for Biomedical Research have identified a new and important molecular player in glioblastoma. The amount of the MNK1 kinase is not only dramatically ...
Mar 18, 2011 |
not rated yet |
0
Imaging against multiple sclerosis: Iodinated radiotracer candidate for PET and SPECT imaging
(PhysOrg.com) -- A first-line treatment for relapsing forms of multiple sclerosis (MS) was approved in September 2010 by the US Food and Drug Administration: FTY720 (fingolimod, Gilenya), which acts as a sphingosine ...
Feb 04, 2011 |
5 / 5 (3) |
0
Bone drug Zometa flops in breast cancer study
(AP) -- Doctors are reporting a stunning setback for a promising new approach for fighting breast cancer.
Dec 09, 2010 |
not rated yet |
0
Chip-in-a-pill may be approved in 2012
(PhysOrg.com) -- Giant Swiss pharmaceutical company Novartis AG, based in Basel, is developing a pill containing an embedded microchip, which it hopes to submit for regulatory approval in Europe within 18 ...
Medicine & Health / Medications
Nov 10, 2010 |
4.9 / 5 (18) |
10
|
FDA approves Novartis brain tumour drug
Swiss pharmaceutical company Novartis said Saturday that the US drug Food and Drug Administration had approved a drug for treating certain benign brain tumours which previously required surgery.
Medicine & Health / Medications
Oct 30, 2010 |
not rated yet |
0
Novartis fined $422.5M in marketing, kickback case
(AP) -- Novartis Pharmaceuticals Corp. will pay $422.5 million in penalties for marketing an epilepsy medicine for unapproved uses and for paying kickbacks to doctors to prescribe it and five other drugs, ...
Medicine & Health / Medications
Sep 30, 2010 |
5 / 5 (1) |
0
CVS Caremark to give away up to $5M in flu shots
(AP) -- CVS Caremark Corp. said Wednesday it will give away up to $5 million in seasonal flu vaccinations to people without health insurance.
Sep 08, 2010 |
not rated yet |
0
FDA relents from midodrine withdrawal plan
(AP) -- Federal regulators have backed off a plan to remove a Shire PLC low blood-pressure treatment from the market after warning in August that the drug has not been proven effective.
Medicine & Health / Medications
Sep 06, 2010 |
not rated yet |
0
Novartis: Ovarian cancer drug disappoints in trial
(AP) -- Swiss drug maker Novartis AG said Thursday it won't ask regulators for permission to market a new ovarian cancer drug after a late-stage trial proved disappointing.
Medicine & Health / Medications
May 27, 2010 |
not rated yet |
1
New steps toward a universal flu vaccine
Researchers at Mt. Sinai School of Medicine have developed a novel influenza vaccine that could represent the next step towards a universal influenza vaccine eliminating the need for seasonal immunizations. They report their ...
Medicine & Health / Medical research
May 19, 2010 |
4 / 5 (1) |
0
Novartis
Novartis International AG is a multinational pharmaceutical company based in Basel, Switzerland, ranking number one in revenues, which accounted over $53 billion in 2008, and number three in sales, which accounted 36.172 billon in 2008 . Novartis is one of the largest healthcare companies in the world and a leading giant among pharmaceutical companies. Novartis manufactures drugs such as clozapine (Clozaril), diclofenac (Voltaren), carbamazepine (Tegretol), valsartan (Diovan), imatinib mesylate (Gleevec / Glivec), cyclosporin A (Neoral / Sandimmun), letrozole (Femara), methylphenidate (Ritalin), terbinafine (Lamisil), and others. Novartis owns Sandoz, a large manufacturer of generic drugs. The company formerly owned the Gerber Products Company, a major infant and baby products producer, but sold it to Nestlé on 1 September 2007.
Novartis is a full member of the European Federation of Pharmaceutical Industries and Associations (EFPIA).
For more information about Novartis, read the full article at
Wikipedia.
This text uses material from Wikipedia and is available under the GNU Free Documentation License.
